Order byBest matchMost fresh

FDA vaccine official Peter Marks slams Rfk Jr.

Digest more
Top News
Impacts
Marks added that “undermining confidence in well-established vaccines” is “irresponsible, detrimental to public health, and a clear danger to our nation's health, safety (,) and security.”
From USA TODAY
RBC Capital analyst Brian Abrahams warned that Marks’ exit could lead to disruptions at the FDA, affecting drug approvals and regulatory flexibility.
From Business Insider

Read more on News Digest

Dr. Peter Marks, top vaccine official at FDA, resigns and criticizes RFK Jr.
Dr. Peter Marks, the top vaccine official at the Food and Drug Administration, wrote in a letter that he was resigning from his position.
Who Is Dr. Peter Marks? FDA’s Top Vaccine Official Quits, Citing RFK Jr.’s ‘Misinformation And Lies.’
Marks offered his resignation while citing Kennedy’s “misinformation and lies” and an “unprecedented assault on scientific truth” impacting public health.
Peter Marks, top FDA vaccine official, forced to resign
Dr. Peter Marks, the top vaccine regulator at the U.S. Food and Drug Administration, was forced to resign, citing Health and Human Services Secretary Robert F. Kennedy Jr.'s "misinformation and lies" around immunization.
Marks’ Resignation Is a ‘Blow for Biotech Industry,’ Says RBC Analyst as Biotech Stocks Fall
Biotech stocks took a hit after the sudden resignation of Dr. Peter Marks, head of the FDA’s Center for Biologics Evaluation and Research
Drugmakers sink after key FDA official ousted as Trump plans health overhaul
Shares of U.S. drugmakers fell on Monday after reports that the Food and Drug Administration's top vaccine official, Peter Marks, had been forced to resign, the most high-profile exit at the regulator as the Trump administration undertakes an overhaul of federal health agencies.
Biotech Investors Rush for the Exits After FDA Official Resigns
Biotech investors are reeling after the sudden departure of Peter Marks, a pivotal figure in the U.S. Food and Drug Administration. Marks, who played a crucial role in Operation Warp Speed and champio
FDA’s top vaccine scientist, Dr. Peter Marks, is out
Dr. Peter Marks, the Food and Drug Administration’s top vaccine regulator, has resigned, an official at the Department of Health and Human Services said Friday.
Top vaccine official Peter Marks forced out at FDA, WSJ reports
The U.S. Food and Drug Administration's top vaccine official, Peter Marks, has been pushed out, the Wall Street Journal reported on Friday.
US FDA misses deadline for decision on Novavax's COVID-19 vaccine
The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's COVID-19 vaccine, the company told Reuters on Wednesday. The delay comes on the heels of the FDA's top vaccine scientist Peter Marks' exit from the agency,
STAT2d
Peter Marks, FDA’s top vaccine regulator, forced out
Top FDA official Peter Marks was forced to resign as the director of the Center for Biologics Evaluation and Research.
Fierce Pharma2d
As FDA's Peter Marks resigns, industry watchers size up vaccine, cell and gene therapy hits
As the FDA wavers from cuts, changes and departures under the second Trump administration, another vital figure of the agency is heading for the exit. | In resigning as director of the FDA’s Center for Biologics Evaluation and Research,
Top F.D.A. Vaccine Official Resigns, Citing Kennedy’s ‘Misinformation and Lies’
Dr. Peter Marks, a veteran of the agency, wrote that undermining confidence in vaccines is irresponsible and a danger to public health.
Top vaccine official sends warning
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Top FDA official’s exit sends ripples through WashingtonPeter Marks, who led the Food and Drug
Top FDA vaccine official Peter Marks resigns in opposition to RFK Jr.
The Food and Drug Administration’s top vaccine regulator Peter Marks has resigned, citing Sec. Kennedy Robert F. Kennedy Jr.’s “misinformation and lies” around immunization.
FDA Misses Deadline for Decision on Novavax's COVID-19 Vaccine, Source Says
Novavax, the FDA and the Department of Health and Human Services did not immediately respond to Reuters' requests for comment. The company had said in February it expects a decision from the agency on its vaccine in April. The vaccine shot was initially authorized for emergency use in 2022.
Feedback